Pharmaceutical

Dotmatics Introduces Luma Antibody & Protein Engineering Solution for End-to-End Antibody Discovery

The first in a series of Dotmatics Luma Multimodal R&D Solutions Geneious has been seamlessly composed into Luma showcasing cross-therapeutic…

3 months ago

Formedics Appoints Helen Moran as Its First Chief Content and Product Officer

- Ms. Moran to lead innovation and drive personalized, peer-to-peer content solutions using Formedics' AI-powered platform for healthcare professionals BASKING…

3 months ago

Positive Partial 12-Week Body Weight Results from Lexaria’s GLP-1 Diabetes Animal Study

DehydraTECH-liraglutide and select DehydraTECH-CBD formulations were the top performing weight loss groupsAccelerated rates of weight loss were experienced during the…

3 months ago

Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in Canada

BOULDER, CO / ACCESSWIRE / October 22, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing…

3 months ago

NanoViricides President Dr. Diwan to Present at the PODD Conference

SHELTON, CT / ACCESSWIRE / October 22, 2024 / NanoViricides, Inc. (NYSE Amer.: NNVC ) (the "Company"), a clinical stage…

3 months ago

Parexel Names Keri Mattox Chief Business Officer

Healthcare executive to lead company’s business operations and growth strategyDURHAM, N.C., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Parexel, one of…

3 months ago

ABVC BioPharma Receives $50,000 in Incremental Licensing Fees, Boosting Total Payments to $346,000 From Its Three Strategic Partners

FREMONT, Calif., Oct. 22, 2024 (GLOBE NEWSWIRE) -- ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company focused on innovative…

3 months ago

Evoke Pharma Announces the Appointment of Ben Smeal to the Board of Directors

SOLANA BEACH, Calif., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on…

3 months ago

Catalyst Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 6, 2024

The Company will Host a Conference Call and Webcast on Thursday, November 7, 2024, at 8:30 AM ETCORAL GABLES, Fla.,…

3 months ago

Allarity Therapeutics to be Granted European Patent for DRP® Companion Diagnostic for Stenoparib

European Patent Office to grant a patent for DRP® companion diagnostic for Allarity’s stenoparib cancer therapy Patent applications for the…

3 months ago